| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 07/18/2002 | US20020095047 Process for preparing hydroxychomanones and CIS-aminochromanols |
| 07/18/2002 | CA2434152A1 Therapeutic heterocyclic compounds |
| 07/18/2002 | CA2434015A1 Therapeutic chroman compounds |
| 07/18/2002 | CA2433950A1 Therapeutic chromone compounds |
| 07/18/2002 | CA2433066A1 Novel multi-ring organic compounds for regulating gut motility and food intake |
| 07/17/2002 | EP1222920A2 Mitochondria protecting agents for treating mitochondria associated diseases |
| 07/17/2002 | EP1222183A1 Benzopyran derivatives |
| 07/17/2002 | EP1100520A4 Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof |
| 07/17/2002 | EP0890119A4 Photochromic naphthopyran compositions of neutral color |
| 07/17/2002 | EP0713486B1 Photochromic naphtho(2,1-b)pyrans |
| 07/17/2002 | CN1359383A Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process |
| 07/17/2002 | CN1358717A Optics decomposing method for coumarin dimer |
| 07/17/2002 | CN1087613C Pharmaceutical preparations having antithrombotic activity and process for preapring same |
| 07/16/2002 | US6420572 Flavanoid derivatives and phenolic derivatives with halogenation |
| 07/16/2002 | US6420131 Monitoring prefrential enzymatic activity; obtain sample of enzymatic polypeptide, incubate with modulator, evaluate the modulator ability to inhibit enzymatic polypeptide |
| 07/16/2002 | US6420130 Chemical compound for use in the detection of preferential enzymatic polypeptide |
| 07/11/2002 | WO2002053553A1 Novel photochromic indenonaphthopyran compounds |
| 07/11/2002 | WO2002053552A1 Process for preparation of esculetin compounds, esculetin compounds and intermediates thereof, and use of both |
| 07/11/2002 | WO2002053522A2 Novel estrogen receptor ligands and methods i |
| 07/11/2002 | US20020091276 Process for the epoxidation of olefins |
| 07/11/2002 | US20020091150 Carbamic acid derivatives |
| 07/11/2002 | US20020091089 (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
| 07/11/2002 | CA2433828A1 Novel estrogen receptor ligands and methods i |
| 07/11/2002 | CA2433578A1 Process for preparation of esculetin compounds, esculetin compounds and intermediates thereof, and use of both |
| 07/10/2002 | EP1221442A1 Epoxidation process of olefins |
| 07/10/2002 | EP1221441A2 LTA4 Hydrolase inhibitors |
| 07/10/2002 | EP1220849A2 Bicyclic compounds composition and method for stabilizing the same |
| 07/10/2002 | EP0517852B1 Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists |
| 07/10/2002 | CN1358169A N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 07/10/2002 | CN1358091A Estrogen receptor-beta ligands |
| 07/09/2002 | US6417370 Arylphenyl-substituted cyclic keto-enols |
| 07/09/2002 | US6417223 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses therof |
| 07/09/2002 | US6417221 Tropane analogs and methods for inhibition of monoamine transport |
| 07/09/2002 | US6417205 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 07/09/2002 | CA2222275C Fluorinated xanthene derivatives |
| 07/09/2002 | CA2221592C Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction |
| 07/04/2002 | WO2002051847A1 Processes for preparing calanolide a and intermediates thereof |
| 07/04/2002 | WO2002051829A1 Flavanol and cysteamine conjugates |
| 07/04/2002 | WO2002051797A1 Novel functional peptide nucleic acid monomer and process for producing the same |
| 07/04/2002 | WO2002005848A3 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 07/04/2002 | US20020086985 Fluorescent dye for use in the detection of preferential compounds |
| 07/04/2002 | US20020086874 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents |
| 07/04/2002 | US20020086833 Cocoa procyanidin oligomer/polymer, a polyphenol-type compound; anticancer agent; antioxidant; DNA topoisomerase II enzyme inhibitors, cyclooxygenase, NO (Nitric Oxide) or NO-synthase modulators, nonsteroidal antiinflammatory agent |
| 07/04/2002 | US20020086438 Method of preparing delta-9-tetrahydrocannabinol |
| 07/03/2002 | EP1219615A2 Method for extracting flavon mixtures and use of mixtures so obtained in dermocosmetic, food and pharmacy |
| 07/03/2002 | EP1218367A1 4-oxybenzopyran derivative |
| 07/03/2002 | EP1218336A2 Melanin concentrating hormone antagonist |
| 07/03/2002 | EP0973761B1 RED COLOURING HYPERCHROMIC 3H-NAPHTHO 2,1-b ]PYRANS |
| 07/03/2002 | EP0968202B1 Process for preparing photoactive coumarin dervatives |
| 07/03/2002 | EP0812185B1 Use of angiogenesis suppressors for inhibiting hair growth |
| 07/03/2002 | CN1357000A Water soluble prodrugs of hindered alcohols or phenols |
| 07/03/2002 | CN1356994A Methods for purifying proanthocyanidin oligomers |
| 07/03/2002 | CN1356327A Process for extracting flavone from pomelo peel |
| 07/02/2002 | US6414166 Process for preparing tocopherol concentrates |
| 07/02/2002 | US6414016 Anti-constipation composition |
| 07/02/2002 | US6413947 Antiinflammatory agents; rheumatic diseases; anticholesterol agents |
| 07/02/2002 | CA2000758C Adamantane derivatives, compositions of matter containing same, processes for preparing said adamantane derivatives and said compositions, and organoleptic and deodorancy uses of said adamantane derivatives and said compositions |
| 06/27/2002 | WO2002050081A2 Antimicrobial agents |
| 06/27/2002 | WO2002050067A2 Pharmaceutical heterocyclic compounds |
| 06/27/2002 | WO2002050054A2 Process for the production of tocotrienols |
| 06/27/2002 | WO2002020509A3 Medicaments against viral infections |
| 06/27/2002 | US20020082419 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
| 06/27/2002 | US20020082292 Agonists of peroxisome proliferator activated receptor (PPAR) alpha and/or gamma |
| 06/27/2002 | US20020082264 Combinations of for the treatment and prophylaxis of hepatitis B comprising: at least one chromanone and/or chromanol, lamivudine, ii) at least one dihydropyrimidine, at one isoxazole and an immunomodulator such as interferon |
| 06/27/2002 | US20020081616 4,7-dichlorofluorescein dyes as molecular probes |
| 06/27/2002 | US20020080451 Novel naphthopyran compounds, photoresponsive compositions and lenses |
| 06/26/2002 | EP1216227A2 Preparation of sulfonyl imine compounds |
| 06/26/2002 | EP1163235A4 Methods for separating a tocopherol from a tocopherol-containing mixture and compositions thereof |
| 06/26/2002 | CN1355799A 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 06/26/2002 | CN1355797A Recovery of isoquercetin from bioflavanoid pastes |
| 06/26/2002 | CN1355796A Synthetic methods for preparing procyanidin ligomers |
| 06/26/2002 | CN1086703C Crystalline hydrochloride of (R)-(-)-2{N-[4-(1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl} benzodihydropyran |
| 06/26/2002 | CN1086576C Hypoglycemic agents |
| 06/25/2002 | US6410755 Method of vitamin production |
| 06/25/2002 | US6410754 Photochromic spiropyrans, and compositions and articles containing same |
| 06/25/2002 | US6410699 Generation of preferential isoflavone glycosides; obtain sample, remove fat from fermented soybeans, incubate with solvent to generate isoflavone glycoside extract, dissolve extract in solvent, wash and recover isoflavone glycoside |
| 06/25/2002 | US6410592 Aminomethylcarboxylic acid derivatives |
| 06/25/2002 | US6410589 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 06/25/2002 | US6410588 Use of cannabinoids as anti-inflammatory agents |
| 06/25/2002 | US6410480 Plant safening agents and growth regulators for controlling weeds and grasses; post/preemergence herbicides |
| 06/25/2002 | CA2215210C Polyphenol fractions of tea, the use thereof and formulations containing them |
| 06/25/2002 | CA2213609C New compounds to modulate hormone receptors, compositions containing them, and their therapeutic use |
| 06/25/2002 | CA2031384C Active component concentrates and new active component combinations from ginkgo biloba leaves, their method of preparation and pharmaceuticals containing the active component concentrates or the active component combinations |
| 06/20/2002 | WO2002048204A1 Surface-active photoinitiators |
| 06/20/2002 | WO2002048134A2 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists |
| 06/20/2002 | WO2002048102A2 Isocoumarin inhibiting production of amyloid peptide, preparation, compositions containing same and uses |
| 06/20/2002 | WO2002047723A1 Medicinal compositions having improved water-solubility |
| 06/20/2002 | WO2002030888A3 Tricyclic compounds and uses thereof |
| 06/20/2002 | WO2001068635A3 Parallel synthesis method for at least two organic colorants and substituted coumarin derivatives and aryl boronic acid and arylboronic acid propanediol esters |
| 06/20/2002 | US20020077333 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (TNF-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (COX-2) |
| 06/20/2002 | US20020076648 Optical data medium containing, in the information layer, a phthalocyanine dye as a light-absorbing compound |
| 06/20/2002 | DE10060677A1 Klainetine und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben Klainetins and their derivatives, process for their preparation and use thereof |
| 06/20/2002 | CA2431619A1 Surface-active photoinitiators |
| 06/20/2002 | CA2430992A1 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists |
| 06/19/2002 | EP1214933A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 06/19/2002 | EP1214311A1 Novel indeno-fused photochromic naphthopyrans |
| 06/19/2002 | EP1214310A1 Novel photochromic naphthopyrans |
| 06/19/2002 | EP1214309A1 Preparing amidines derived from 6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid |
| 06/19/2002 | EP1214308A2 Novel flavonoids |
| 06/19/2002 | EP1214307A1 4-oxybenzopyran derivative |